Get a better handle of your forecasting and eliminate hidden costs.
For life sciences companies that don’t have automated financial data-gathering systems and depend a lot on excel, calculating an error-free financial accrual rate is a costly chore. Accuracy is extremely important, as errors can negatively impact rebates and promotions. They can also lead to funds being added or subtracted from the wrong areas of business, possibly leading to stunted revenue, cash crunches or excessive borrowing to fulfill obligations.
At EVERSANA we partner with our clients to evaluate their processes and offer strategic support that counter these gross-to-net challenges with:
- Gross-to-net automation and process improvements
- Best price projections
- Insights into contracting strategy impacts on Medicaid liability
- Optimization of WAC price strategy